DOCKETS MANAGEMENT

Dockets Entered On July 8, 2003

Table of Contents (Linked)

Docket #

Title

2003P-0307

ANDA suitability for a new strength of Wararin Sodium Tablets, USP 1.5mg

Contents

1988F-0182

STYRENE-BUTADIENE-ACRYLONITRILE COPOLYMERS

NWL 1

FDA

Vol #:

1

1988F-0340

POLY-1-BUTENE RESINS/BUTENE/ETHYLENE COPOLYMERS

NWL 1

FDA

Vol #:

1

1992F-0315

Safe Use of Rubber-Modified Polystyrene; Use of Octadecyl 3

NWL 1

FDA

Vol #:

1

1994F-0290

Safe use of ethylene-1,4-cyclohexylene dimethylene

NWL 1

FDA

Vol #:

1

1995F-0021

Safe Use Of Ethylene Terephthalate-Isophthalate Copolymers

NWL 1

FDA

Vol #:

1

1997F-0170

Polyester-epoxy-urethane Adhesive for use as nonfood contact

NWL 1

FDA

Vol #:

1

1997F-0284

Resinous and Polymeric Coatings in Contact with Food

NWL 1

FDA

Vol #:

1

1998F-0391

C.I. Pigment Red 178

NWL 1

FDA

Vol #:

1

1998F-0706

Colorants for Polymers

NWL 1

FDA

Vol #:

1

1999F-0720

Safe use hydrogenated aromatic petroleum hydrocarbon

NWL 1

FDA

Vol #:

1

1999F-4694

2-methyl-4-isothiazolin-3-one as an antimicrobial

NWL 1

FDA

Vol #:

1

2000F-1366

Methylmethacrylate-trimethylolpropane Trimethacrylate Copoly

NWL 1

FDA

Vol #:

1

2000N-1396

Bioengineered Foods Consumed By Humans or Animals

EMC 11566

Eli Sterling

Vol #:

349

EMC 11567

Erik Callaway

Vol #:

349

2000N-1571

Enrofloxacin for Poultry: Opportunity for Hearing

EXB 21

Bayer Corporation

Vol #:

379

EXB 22

Bayer Corporation

Vol #:

379

EXB 23

Bayer Corporation

Vol #:

379

EXB 24

Bayer Corporation

Vol #:

379

2000P-0685

Revise of Yogurt Standards

NAP 1

FDA

Vol #:

1

2002D-0080

Streamlining Donor Interview Process: Recommendations for

GDL 2

Guideline

Vol #:

1

NAD 2

FDA

Vol #:

1

2002N-0277

Bioterrorism; Establishment & Maintenance of Records

EC 49

Chino, Yasuyuki

Vol #:

8

2002N-0354

Long-term Antibiotic Drug Therapy Involving Anthrax;Emergenc

NAL 2

FDA

Vol #:

1

2002N-0496

Large & Small Volume Parenterals Used in Total Parenteral Nu

NAL 1

FDA

Vol #:

1

2002P-0177

Health Claim: D-tagatose and Noncariogenicity

NFR 1

FDA

Vol #:

2

2003N-0066

Inspection by Accredited Persons Under MDUFMA

SS 1

Supporting Statement

Vol #:

1

2003N-0201

Minimizing Medication Errors - Methods for Evaluating Proprietary Names for their Confusion Potential; Public Meeting

NCR 2

FDA

Vol #:

1

2003N-0286

Agency Information Collection Activities: Proposed Collection; Comment Request; User Fee Cover Sheet; Form FDA 3397

N 1

FDA

Vol #:

1

2003P-0307

ANDA suitability for a new strength of Wararin Sodium Tablets, USP 1.5mg

ACK 1

HFA-305 to Taro Pharmaceuticals

Vol #:

1

CP 1

Taro Pharmaceuticals

Vol #:

1

Attachment 1, 2